Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience

Miray Karakoyun1, Cigdem O Ecevit, Erhan Kilicoglu

  • 1aDepartment of Pediatric Gastroenterology, Hepatalogy and Nutrition, Gaziantep Children's Hospital, Gaziantep bDepartment of Pediatric Gastroenterology, Hepatology and Nutrition cDepartment of Pediatrics, Dr. Behcet Uz Children's Hospital dDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Ege University, Izmir, Turkey.

Insights

Autoimmune hepatitis (AIH) in Turkish children is predominantly type 1, with most responding well to prednisolone. Long-term treatment with low-dose corticosteroids and azathioprine shows a low relapse rate and manageable side effects.

Area of Science:

  • Pediatric Hepatology
  • Autoimmune Diseases
  • Clinical Immunology

Background:

  • Autoimmune hepatitis (AIH) is a chronic liver disease of unknown etiology.
  • Pediatric AIH presents with diverse clinical and laboratory features.
  • Understanding regional variations in AIH is crucial for effective management.

Purpose of the Study:

  • To characterize clinic and laboratory features of pediatric AIH in Turkey.
  • To evaluate treatment protocols and responses in children with AIH.
  • To assess long-term follow-up, relapse rates, and side effects of AIH treatment.

Main Methods:

  • Retrospective analysis of 47 children diagnosed with AIH between 1998 and 2012.
  • Data collected included clinical presentation, autoantibody profiles, treatment regimens, and outcomes.
  • Statistical analysis of clinical, laboratory, and treatment data.

Main Results:

  • AIH type 1 was most prevalent (85.1%) in children, typically presenting in the second decade of life.
  • Prednisolone induced complete remission in 86.4% of patients.
  • Combination therapy with low-dose steroids and thiopurine resulted in a low relapse rate (9.4%) and minimal treatment side effects.

Conclusions:

  • Autoimmune hepatitis type 1 is the predominant form in Turkish children.
  • Low-dose corticosteroids combined with azathioprine represent an effective maintenance therapy for pediatric AIH.
  • Long-term management can achieve sustained remission with acceptable safety profiles.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
6
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313